WAY-100635 maleate
CAS No. 634908-75-1
WAY-100635 maleate ( WAY 100635 maleate salt;WAY100635 maleate salt )
产品货号. M15399 CAS No. 634908-75-1
WAY-100635 is a potent and selective 5-HT1A receptor antagonist; also acts as potent full agonist at the D4 receptor.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥308 | 有现货 |
|
5MG | ¥494 | 有现货 |
|
10MG | ¥778 | 有现货 |
|
25MG | ¥1312 | 有现货 |
|
50MG | ¥1928 | 有现货 |
|
100MG | ¥2851 | 有现货 |
|
500MG | ¥6877 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称WAY-100635 maleate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述WAY-100635 is a potent and selective 5-HT1A receptor antagonist; also acts as potent full agonist at the D4 receptor.
-
产品描述WAY-100635 is a potent and selective 5-HT1A receptor antagonist; also acts as potent full agonist at the D4 receptor; completely prevents not only the hyperpolarization, with an IC50 of 1.3 nM, but also the decrease in membrane input resistance produced by 5-HT and 5-carboxamidotryptamine with IC50 of 22.5 μM and 50 nM, respectively.Anxiety Phase 1 Discontinued
-
同义词WAY 100635 maleate salt;WAY100635 maleate salt
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT1A
-
研究领域Neurological Disease
-
适应症Anxiety
化学信息
-
CAS Number634908-75-1
-
分子量538.64
-
分子式C29H38N4O6
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 34 mg/mL
-
SMILESCOC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.C(=CC(=O)O)C(=O)O
-
化学全称Cyclohexanecarboxamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-, (2Z)-2-butenedioate (9CI)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Corradetti R, et al. J Pharmacol Exp Ther. 1996 Aug;278(2):679-88.
2. Fornal CA, et al. J Pharmacol Exp Ther. 1996 Aug;278(2):752-62.
3. García G, et al. Eur J Med Chem. 2014 Oct 6;85:795-806.
2. Fornal CA, et al. J Pharmacol Exp Ther. 1996 Aug;278(2):752-62.
3. García G, et al. Eur J Med Chem. 2014 Oct 6;85:795-806.
产品手册
关联产品
-
WAY 163909
A highly potent, subtype-selective agonist of 5-HT2C receptor with Ki of 10.5 nM.
-
AVN-322 free base
A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia.
-
SR-57227
SR-57227 is a high affinity, selective 5-HT3 receptor agonist, demonstrates anticonvulsant effects in vivo.